• Je něco špatně v tomto záznamu ?

Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy

P. Hrabalova, R. Bohuslavova, K. Matejkova, F. Papousek, D. Sedmera, P. Abaffy, F. Kolar, G. Pavlinkova

. 2023 ; 22 (1) : 88. [pub] 20230418

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011755

BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms responsible for disruption of this well-organized system are the subject of intensive investigations, the exact processes controlling the cardiac sympathetic nervous system are still not fully understood. A conditional knockout of the Hif1a gene was reported to affect the development of sympathetic ganglia and sympathetic innervation of the heart. This study characterized how the combination of HIF-1α deficiency and streptozotocin (STZ)-induced diabetes affects the cardiac sympathetic nervous system and heart function of adult animals. METHODS: Molecular characteristics of Hif1a deficient sympathetic neurons were identified by RNA sequencing. Diabetes was induced in Hif1a knockout and control mice by low doses of STZ treatment. Heart function was assessed by echocardiography. Mechanisms involved in adverse structural remodeling of the myocardium, i.e. advanced glycation end products, fibrosis, cell death, and inflammation, was assessed by immunohistological analyses. RESULTS: We demonstrated that the deletion of Hif1a alters the transcriptome of sympathetic neurons, and that diabetic mice with the Hif1a-deficient sympathetic system have significant systolic dysfunction, worsened cardiac sympathetic innervation, and structural remodeling of the myocardium. CONCLUSIONS: We provide evidence that the combination of diabetes and the Hif1a deficient sympathetic nervous system results in compromised cardiac performance and accelerated adverse myocardial remodeling, associated with the progression of diabetic cardiomyopathy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011755
003      
CZ-PrNML
005      
20240624143907.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12933-023-01824-5 $2 doi
035    __
$a (PubMed)37072781
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hrabalova, Petra $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, BIOCEV, Vestec, Czechia $u Charles University, Prague, Czechia
245    10
$a Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy / $c P. Hrabalova, R. Bohuslavova, K. Matejkova, F. Papousek, D. Sedmera, P. Abaffy, F. Kolar, G. Pavlinkova
520    9_
$a BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms responsible for disruption of this well-organized system are the subject of intensive investigations, the exact processes controlling the cardiac sympathetic nervous system are still not fully understood. A conditional knockout of the Hif1a gene was reported to affect the development of sympathetic ganglia and sympathetic innervation of the heart. This study characterized how the combination of HIF-1α deficiency and streptozotocin (STZ)-induced diabetes affects the cardiac sympathetic nervous system and heart function of adult animals. METHODS: Molecular characteristics of Hif1a deficient sympathetic neurons were identified by RNA sequencing. Diabetes was induced in Hif1a knockout and control mice by low doses of STZ treatment. Heart function was assessed by echocardiography. Mechanisms involved in adverse structural remodeling of the myocardium, i.e. advanced glycation end products, fibrosis, cell death, and inflammation, was assessed by immunohistological analyses. RESULTS: We demonstrated that the deletion of Hif1a alters the transcriptome of sympathetic neurons, and that diabetic mice with the Hif1a-deficient sympathetic system have significant systolic dysfunction, worsened cardiac sympathetic innervation, and structural remodeling of the myocardium. CONCLUSIONS: We provide evidence that the combination of diabetes and the Hif1a deficient sympathetic nervous system results in compromised cardiac performance and accelerated adverse myocardial remodeling, associated with the progression of diabetic cardiomyopathy.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a experimentální diabetes mellitus $x chemicky indukované $x genetika $x komplikace $7 D003921
650    12
$a diabetická kardiomyopatie $x genetika $7 D058065
650    _2
$a srdce $x inervace $7 D006321
650    _2
$a myokard $x metabolismus $7 D009206
650    _2
$a sympatický nervový systém $x metabolismus $7 D013564
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bohuslavova, Romana $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, BIOCEV, Vestec, Czechia
700    1_
$a Matejkova, Katerina $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, BIOCEV, Vestec, Czechia
700    1_
$a Papousek, Frantisek $u Institute of Physiology CAS, Prague, Czechia
700    1_
$a Sedmera, David $u Institute of Physiology CAS, Prague, Czechia $u Institute of Anatomy, Charles University, Prague, Czechia
700    1_
$a Abaffy, Pavel $u Laboratory of Gene Expression, Institute of Biotechnology CAS, BIOCEV, Vestec, Czechia
700    1_
$a Kolar, Frantisek $u Institute of Physiology CAS, Prague, Czechia
700    1_
$a Pavlínková, Gabriela, $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology CAS, BIOCEV, Vestec, Czechia. gpavlinkova@ibt.cas.cz $d 1966- $7 xx0319150
773    0_
$w MED00008211 $t Cardiovascular diabetology $x 1475-2840 $g Roč. 22, č. 1 (2023), s. 88
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37072781 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20240624143905 $b ABA008
999    __
$a ok $b bmc $g 1963915 $s 1198020
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 22 $c 1 $d 88 $e 20230418 $i 1475-2840 $m Cardiovascular diabetology $n Cardiovasc Diabetol $x MED00008211
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Možnosti archivace